Hereditary hemochromatosis

Hereditary hemochromatosis
Joseph Mathew, May Y Leong, Nick Morley and Alastair D Burt · CC BY 2.0 · source
Name	Hereditary hemochromatosis
Synonyms	Hereditary haemochromatosis

Hereditary hemochromatosis is a genetic disorder characterized by increased intestinal iron absorption leading to progressive iron overload in multiple organs. It presents with variable penetrance and a spectrum of clinical manifestations ranging from asymptomatic biochemical abnormalities to cirrhosis, diabetes, arthropathy, and cardiomyopathy. Often identified in adulthood, the condition has implications for familial screening, population genetics, and public health strategies.

Introduction

Hereditary hemochromatosis was first described in clinical literature during the 19th century and has been studied in contexts involving Harvard Medical School, Royal College of Physicians, Mayo Clinic, Johns Hopkins Hospital, and other academic centers where metabolism and hepatology research advanced. Major milestones in understanding include work at institutions such as Massachusetts General Hospital, University of Cambridge, University of Oxford, Karolinska Institutet, and laboratories associated with the National Institutes of Health, which contributed to elucidating iron homeostasis alongside researchers from Cold Spring Harbor Laboratory, Max Planck Society, and University of California, San Francisco. Clinical practice guidelines developed by bodies like the American Association for the Study of Liver Diseases and international collaborations have informed screening and management.

Genetics and Pathophysiology

Pathogenic variants in the gene most commonly implicated were identified through collaborations among geneticists at University College London, Imperial College London, Wellcome Trust Sanger Institute, and research groups linked to the Human Genome Project and European Molecular Biology Laboratory. The canonical mutation shows autosomal recessive inheritance patterns studied in cohorts from Iceland, Ireland, Scotland, Norway, and Sweden. Molecular studies conducted at Stanford University, Harvard University, Yale University, and Columbia University elucidated interactions among proteins encoded by genes characterized in laboratories at The Rockefeller University and University of Pennsylvania. Dysregulation of hepcidin and ferroportin pathways was clarified through experiments performed at centers such as Princeton University, MIT, ETH Zurich, and University of Tokyo, linking cellular iron export, transferrin saturation, and ferritin deposition.

Clinical Presentation and Complications

Patients may present to clinics affiliated with Cleveland Clinic, Karolinska University Hospital, Toronto General Hospital, Addenbrooke's Hospital, and regional hepatology services with nonspecific symptoms; specialist referrals often involve endocrinology clinics at Mayo Clinic, Massachusetts General Hospital, and University College Hospital. Common complications documented in case series from Guy's and St Thomas' NHS Foundation Trust, Royal Free Hospital, and tertiary centers in Barcelona and Milan include hepatic fibrosis and hepatocellular carcinoma, for which surveillance protocols reference oncology expertise at MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Other organ system involvement, such as pancreatic beta-cell dysfunction leading to diabetes mellitus, arthropathy managed by rheumatology services at Hospital for Special Surgery, and cardiac conduction disease treated in cardiology departments at Johns Hopkins Hospital, demonstrates the multisystem impact observed in registries compiled by networks like the European Association for the Study of the Liver and national cohorts in Australia and New Zealand.

Diagnosis

Diagnostic algorithms evolved through consensus conferences co-sponsored by organizations including the World Health Organization, European Society of Cardiology, American Diabetes Association, and regional health authorities in Canada and Germany. Typical laboratory evaluation initiated in outpatient settings at institutions such as Royal Perth Hospital and Sahlgrenska University Hospital includes serum transferrin saturation and ferritin measurements, interpreted alongside genetic testing undertaken in molecular diagnostics laboratories at Baylor College of Medicine, GeneDx, and academic sequencing centers like Broad Institute. Imaging modalities—magnetic resonance imaging protocols standardized by radiology departments at Mayo Clinic and Cleveland Clinic—assess hepatic iron concentration, while liver biopsy is performed selectively at hepatology centers in Paris and Vienna for staging and exclusion of comorbidities.

Management and Treatment

Therapeutic phlebotomy remains the mainstay of treatment, implemented in hematology units across hospitals such as Royal Melbourne Hospital, John Radcliffe Hospital, and community blood services coordinated with organizations like the American Red Cross and NHS Blood and Transplant. Iron chelation therapy, developed and trialed with involvement from pharmaceutical research groups collaborating with GlaxoSmithKline, Novartis, Roche, and academic centers, is reserved for patients intolerant of phlebotomy or with secondary iron overload. Management of complications involves multidisciplinary teams: hepatology input for surveillance strategies derived from studies at Mount Sinai Hospital and St. Vincent's Hospital, endocrinology management for metabolic complications guided by work at UCSF Medical Center, cardiology care for iron cardiomyopathy informed by research at Brigham and Women's Hospital, and orthopedic interventions coordinated with centers like Mayo Clinic for arthropathy.

Epidemiology and Public Health Implications

Population studies from national registries in Ireland, Scotland, France, Spain, United States, Canada, Australia, and New Zealand have characterized allele frequencies and phenotypic penetrance, informing screening debates in policy forums convened by agencies such as the Centers for Disease Control and Prevention, Public Health England, and the European Centre for Disease Prevention and Control. Genetic counseling services provided by programs at Genetic Alliance, ERIC – European Research Institute for the Biology of Ageing, and university clinics in Berlin and Rome support cascade testing of relatives. Public health strategies balance population screening, targeted testing in high-prevalence groups—as assessed in demographic surveys from Iceland and Scandinavia—and resource allocation modeled by health economists at London School of Economics and Harvard T.H. Chan School of Public Health.

Category:Genetic diseases